Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II... see more

GREY:IVITF - Post Discussion

View:
Post by Medinecheck on Aug 14, 2019 11:56am

Reality

No wonder that big investors haven t Invictus on the Radar. Theire calculations are disturbed !

Source Tilray financial quarter results, guess our co. is in the same trouble ..

Average net selling price per gram decreased to $4.61 (C$6.12) compared to $6.38 (C$8.36) in the prior year period. The average net selling price excluding excise taxes was $3.92 (C$5.20
Read more at https://stockhouse.com/news/press-releases/2019/08/13/tilray-inc-reports-second-quarter-2019-financial-results#vuhtcrPJ1GbMBAgB.99
Comment by Yowza123 on Aug 14, 2019 3:53pm
Invictus released its cost per gram in a June news release to be $5.95 gram/ cdn. Hopefully when the German Demecan deal finally goes through we might see this average back up. Vancouver, BC, June 12, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that the ...more  
Comment by display_name on Aug 14, 2019 4:08pm
Being able to sell at $5.95/g is huge, I am not sure what you guys are tlaking about to be honest. Current spot price average is like $3. The fact that we're consistently selling at almost 2x the industry spot price average makes it a self-evident fact that the product they are growing is superior to a lot of the existing market inventory. https://reports.cannabisbenchmarks.com/ "The ...more  
Comment by Yowza123 on Aug 14, 2019 5:32pm
You're comparing $2.95 and 3.29 US to $5.95 cdn...
Comment by display_name on Aug 14, 2019 6:46pm
Good catch I guess that's like 4.50 usd then - point still stands though I think we're selling at a very healthy price point compared to the broader market. I am more concerned about what the operational cost to grow per gram is than what price point we can sell at to be honest.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities